However, this plan is *not* designed for individuals that have extremely limited mobility, cannot stand for extended periods of time, or have difficulties completing activities of daily living
Follow Dave Asprey and explore their bibliography from Amazon's Dave Asprey Author Page.
All patients received standard care, half given Rybelsus and half given a placebo
GLP-1s should be avoided in anyone with a personal or family history of MTC or MEN2 (Multiple Endocrine Neoplasia Type 2)
In further embodiments, the auris formulation or composition contains a viscosity enhancing agent or viscosity modulating agent sufficient to provide a viscosity of between about 10 and 1,000,000 centipoise, between about 100 and 1,000,000 centipoise, between about 500 and 1,000,000 centipoise, between about 750 and 1,000,000 centipoise